• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔癌患者手术后及辅助治疗后发生颌骨坏死的风险因素:化疗的潜在作用。

Risk factors for osteonecrosis of the jaw in oral cancer patients after surgery and eventual adjuvant treatment: The potential role of chemotherapy.

机构信息

Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taiwan.

Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taiwan; Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.

出版信息

Radiother Oncol. 2017 Jun;123(3):406-411. doi: 10.1016/j.radonc.2017.05.001. Epub 2017 May 19.

DOI:10.1016/j.radonc.2017.05.001
PMID:28532609
Abstract

BACKGROUND AND PURPOSE

To identify the risk factors for osteonecrosis of the jaw (ONJ) in oral cancer patients after surgery with and without adjuvant therapy in a nationwide, population-based study.

MATERIAL AND METHODS

Using the Taiwan National Health Insurance Research Dataset, we recruited patients with newly diagnosed oral cancer between 1997 and 2011. All of them underwent primary surgery. Data regarding demographic characteristics; tooth extractions; medications; and cancer treatments, including types of mandibular surgery, radiotherapy and platinum-based chemotherapy, were collected for analysis.

RESULTS

We identified 25,858 patients who suffered 2802 ONJ events. The ONJ incidence rate was 3.45 per 100 person-years. Lip cancer was associated with the highest risk of ONJ, followed by buccal mucosa, gum, mouth floor and tongue cancer. Using a time-dependent Cox regression model, multivariable analysis demonstrated that mandibulotomy (hazard ratio (HR), 1.25; 95% confidence interval (CI), 1.01-1.55; p<0.001), radiotherapy (HR, 1.39; 95% CI, 1.26-1.54; p<0.001) and platinum-based chemotherapy (HR, 1.94; 95% CI, 1.56-2.41; p<0.001) were significant risk factors for ONJ. In the subgroup analysis of patients receiving radiotherapy and patients not receiving radiotherapy, platinum-based chemotherapy remained a risk factor for ONJ.

CONCLUSIONS

Mandibulotomy, radiotherapy and platinum-based chemotherapy were associated with an increased ONJ risk. Chemotherapy was a risk factor regardless of whether radiotherapy was administered.

摘要

背景与目的

本项全国性基于人群的研究旨在确定口腔癌患者在接受手术及辅助治疗后发生颌骨坏死(ONJ)的风险因素。

材料与方法

利用台湾全民健康保险研究数据库,我们招募了 1997 年至 2011 年间新诊断为口腔癌的患者。所有患者均接受了初次手术。收集了人口统计学特征、拔牙、药物以及癌症治疗(包括下颌骨手术类型、放疗和铂类化疗)相关数据进行分析。

结果

我们共确定了 25858 例患者,其中 2802 例患者发生了 ONJ 事件。ONJ 的发生率为每 100 人年 3.45 例。唇癌患者的 ONJ 风险最高,其次为颊黏膜、牙龈、口底和舌癌患者。采用时依 Cox 回归模型进行多变量分析,结果表明下颌骨切开术(危险比(HR),1.25;95%置信区间(CI),1.01-1.55;p<0.001)、放疗(HR,1.39;95%CI,1.26-1.54;p<0.001)和铂类化疗(HR,1.94;95%CI,1.56-2.41;p<0.001)是 ONJ 的显著风险因素。在接受放疗和未接受放疗的患者亚组分析中,铂类化疗仍然是 ONJ 的风险因素。

结论

下颌骨切开术、放疗和铂类化疗与 ONJ 风险增加相关。是否接受放疗,化疗都是 ONJ 的风险因素。

相似文献

1
Risk factors for osteonecrosis of the jaw in oral cancer patients after surgery and eventual adjuvant treatment: The potential role of chemotherapy.口腔癌患者手术后及辅助治疗后发生颌骨坏死的风险因素:化疗的潜在作用。
Radiother Oncol. 2017 Jun;123(3):406-411. doi: 10.1016/j.radonc.2017.05.001. Epub 2017 May 19.
2
The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.台湾地区双膦酸盐相关颌骨坏死的全国性队列研究。
J Dent. 2014 Oct;42(10):1343-52. doi: 10.1016/j.jdent.2014.05.001. Epub 2014 Jun 4.
3
Identification of predisposing factors for osteonecrosis of the jaw after marginal mandibulectomy in the surgical management of oral squamous cell carcinoma.口腔鳞状细胞癌手术治疗中下颌骨边缘切除术后颌骨坏死诱发因素的识别。
J Surg Oncol. 2018 Mar;117(4):781-787. doi: 10.1002/jso.24913. Epub 2017 Nov 22.
4
Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel.唑来膦酸和多西他赛治疗转移性前列腺癌导致的白细胞减少症是下颌骨坏死的危险因素。
BJU Int. 2012 Dec;110(11 Pt B):E520-5. doi: 10.1111/j.1464-410X.2012.11205.x. Epub 2012 May 11.
5
Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.双膦酸盐类药物所致颌骨坏死:80例多发性骨髓瘤及其他恶性肿瘤患者的前瞻性研究
Oral Oncol. 2008 Sep;44(9):857-69. doi: 10.1016/j.oraloncology.2007.11.012. Epub 2008 Feb 20.
6
Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.双膦酸盐相关性颌骨骨坏死癌症患者的危险因素的纵向队列研究。
J Clin Oncol. 2009 Nov 10;27(32):5356-62. doi: 10.1200/JCO.2009.21.9584. Epub 2009 Oct 5.
7
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.关于口服双膦酸盐治疗的骨质疏松症患者颌骨坏死的文献综述:患病率、危险因素及临床特征
Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008.
8
Positive predictive value of the International Classification of Diseases, 10th revision, codes to identify osteonecrosis of the jaw in patients with cancer.国际疾病分类第 10 版编码对癌症患者颌骨坏死的阳性预测值。
Cancer Epidemiol. 2012 Aug;36(4):381-3. doi: 10.1016/j.canep.2012.03.012. Epub 2012 Apr 24.
9
Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database.自发报告数据库中的知名度偏差:以法国国家药物警戒数据库中双膦酸盐治疗下的颌骨坏死为例。
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):989-92. doi: 10.1002/pds.3622. Epub 2014 Apr 15.
10
The association with xerostomia from sialadenitis and the jaw osteonecrosis in head and neck cancer population: a nationwide cohort study.唾液腺炎和头颈部癌症人群中颌骨坏死与口干症的关联:一项全国性队列研究。
Clin Oral Investig. 2019 Feb;23(2):585-593. doi: 10.1007/s00784-018-2465-3. Epub 2018 May 3.

引用本文的文献

1
Reply to "Proactive Customized Protocol for Oral Management in Head and Neck Cancer Patients Planned for Radiotherapy".对“针对计划接受放疗的头颈癌患者的口腔管理主动定制方案”的回复
J Maxillofac Oral Surg. 2025 Jun;24(3):723-724. doi: 10.1007/s12663-025-02509-0. Epub 2025 Mar 20.
2
Diagnostic and Therapeutic Approaches to Jaw Osteoradionecrosis.颌骨放射性骨坏死的诊断与治疗方法
Diagnostics (Basel). 2024 Nov 27;14(23):2676. doi: 10.3390/diagnostics14232676.
3
Advances in mechanism and management of bone homeostasis in osteonecrosis: a review article from basic to clinical applications.
骨坏死中骨稳态的机制与管理进展:一篇从基础到临床应用的综述文章
Int J Surg. 2025 Jan 1;111(1):1101-1122. doi: 10.1097/JS9.0000000000002094.
4
Research Progress of Polydopamine Hydrogel in the Prevention and Treatment of Oral Diseases.聚多巴胺水凝胶在口腔疾病防治中的研究进展。
Int J Nanomedicine. 2023 May 16;18:2623-2645. doi: 10.2147/IJN.S407044. eCollection 2023.
5
A Custom Mouthpiece With Lip Bumper for Osteoradionecrosis Risk Reduction After Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Lip.一种带有唇挡的定制口器,用于降低唇部腺样囊性癌碳离子放射治疗后放射性骨坏死的风险。
Adv Radiat Oncol. 2022 Oct 22;8(1):101114. doi: 10.1016/j.adro.2022.101114. eCollection 2023 Jan-Feb.
6
Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort.牙科实践中与药物相关的颌骨坏死:来自米兰队列的数据回顾性分析
Dent J (Basel). 2022 May 19;10(5):89. doi: 10.3390/dj10050089.
7
The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw.免疫反应在药物相关性颌骨坏死发展中的作用。
Front Immunol. 2021 Feb 25;12:606043. doi: 10.3389/fimmu.2021.606043. eCollection 2021.
8
Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study.直肠癌幸存者放疗后骨盆骨折风险增加:一项倾向匹配研究。
Cancer Med. 2019 Jul;8(8):3639-3647. doi: 10.1002/cam4.2030. Epub 2019 May 18.